Gentian Diagnostics ASA (OSL:GENT)
Norway · Delayed Price · Currency is NOK 39.70
-0.30 (-0.75%)
Aug 4, 2026, 3:32 PM CET
Gentian Diagnostics ASA Financials Overview
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 182.12 | 176.5 | 152.07 | 135.15 | 111.92 | 100.01 |
Revenue Growth | 11.47% | 16.06% | 12.52% | 20.76% | 11.91% | 26.78% |
Gross Profit Gross Profit Growth | 101.1 | 98.2 | 82.82 | 64.25 | 59.29 | 56.83 |
Operating Income Operating Income Growth | -7.34 | 25.45 | 15.72 | -12.76 | -23.24 | -22.85 |
Net Income Net Income Growth | -8.41 | 13.26 | 45.29 | -10.65 | -23.62 | -24.79 |
Earnings Per Share EPS Growth | -0.55 | 0.86 | 2.87 | -0.69 | -1.53 | -1.61 |
EPS Growth | - | -70.03% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Europe Europe Growth | 119.97 | 114.18 | 116.17 | 92.76 | 71.57 | 55.68 |
Asia Asia Growth | 24.61 | 32.88 | 23.72 | 33.67 | 23.61 | 25.01 |
USA USA Growth | 37.54 | 29.44 | 12.19 | 8.72 | 6.46 | 2.44 |
Total Total Growth | 182.12 | 176.5 | 152.07 | 135.15 | 101.64 | 83.12 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 79.34 | 105.93 | 84.74 | 87.64 | 81.6 | 114.94 |
Total Debt Total Debt Growth | 16.81 | 22.99 | 10.04 | 13.05 | 15.32 | 18.58 |
Net Cash (Debt) Net Cash Growth | 62.53 | 82.94 | 74.7 | 74.59 | 66.28 | 96.35 |
Net Cash Growth | -18.89% | 11.03% | 0.14% | 12.55% | -31.21% | -29.00% |
Net Cash Per Share Net Cash Per Share Growth | 4.04 | 5.35 | 4.74 | 4.84 | 4.05 | 5.96 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 19.28 | 42.59 | 13.46 | 15.46 | -13.95 | -27.05 |
Capital Expenditures CapEx Growth | -1.01 | -1.21 | -1.38 | -0.96 | -8.64 | -1.02 |
Free Cash Flow Free Cash Flow Growth | 18.27 | 41.38 | 12.08 | 14.5 | -22.59 | -28.08 |
Free Cash Flow Growth | -5.18% | 242.57% | -16.71% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 55.51% | 55.64% | 54.46% | 47.54% | 52.97% | 56.83% |
Operating Margin | -4.03% | 14.42% | 10.34% | -9.44% | -20.76% | -22.84% |
Pretax Margin | -2.75% | 14.54% | 13.19% | -7.67% | -21.10% | -24.79% |
Profit Margin | -4.62% | 7.51% | 29.78% | -7.88% | -21.10% | -24.79% |
FCF Margin | 10.03% | 23.45% | 7.94% | 10.73% | -20.18% | -28.07% |
| Fiscal Year | Current | FY 2025 | FY 2024 |
|---|---|---|---|
| Period Ending | Aug '26 Aug 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Dividend Per Share Dividend Per Share Growth | 0.600 | 0.600 | 0.400 |
Dividend Per Share Growth | 0% | 50.00% | - |
Dividend Yield | 1.50% | 0.71% | 0.00% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 65.58 | 13.66 | - | - | - |
Forward PE | 27.19 | 29.00 | 28.52 | - | - | - |
P/FCF Ratio | 33.59 | 21.02 | 50.04 | 44.13 | - | - |
PS Ratio | 3.37 | 4.93 | 3.98 | 4.74 | 5.65 | 11.10 |